Isolation of two forms of decay-accelerating factor (DAF) from human urine.

Article Details

Citation

Nakano Y, Sugita Y, Ishikawa Y, Choi NH, Tobe T, Tomita M

Isolation of two forms of decay-accelerating factor (DAF) from human urine.

Biochim Biophys Acta. 1991 Jul 8;1074(2):326-30.

PubMed ID
1712233 [ View in PubMed
]
Abstract

Decay-accelerating factor (DAF) was purified from human pooled urine by conventional techniques. The urine DAF was separated into two peaks, pool I and pool II, by gel chromatography. DAF-U1 was isolated from pool I by hydrophobic chromatography, and DAF-U2 from pool II by anti-DAF IgG column. The specific activities of DAF-U1 and DAF-U2 to decay membrane-phase C5 convertase were about 3% and 70% of membrane form DAF, respectively. However, both urine DAFs revealed a similar activity to each other and slightly higher activity than that of membrane form DAF in decay-accelerating fluid-phase C3 convertase of the alternative pathway.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Complement decay-accelerating factorP08174Details